Lynk Biotechnologies Pte Ltd – Logistic Intern

Company
Lynk Biotechnologies Pte Ltd
lynkbiotech.com
Designation
Logistic Intern
Date Listed
12 Jul 2022
Job Type
Entry Level / Junior Executive
Intern/TS
Job Period
From Sep 2022, For At Least 4 Months
Profession
Logistics / Supply Chain / Transport
Industry
Manufacturing General / Biomedical / Pharmaceutical
Location Name
Lorong 21 Geylang, Greatland Building, Singapore
Address
48 Lor 21 Geylang, Singapore 388464
Map
Allowance / Remuneration
$800 - 1,000 monthly
Company Profile

Lynk Biotechnologies Pte Ltd (Lynk Biotech) is a fast expanding Singapore-based pharmaceutical company dedicated to the application of revolutionary technologies for the design and development of innovative healthcare and cosmetic products and services. Spun off from National University of Singapore (NUS) in 2000 by Associate Professor Lee Chee Wee from the Yong Loo Lin School of Medicine.

Lynk Biotech is also the parent company of DynaLynk Pharma Pte Ltd, a state-of-the-art manufacturing facility that has pharmaceutical GMP (Good Manufacturing Practice) certification accredited by the Health Sciences Authority of Singapore (HSA).  Besides the large scale manufacturing capabilities of DynaLynk Pharma, Lynk Biotech also possesses smaller scale pilot batch manufacturing capabilities.  These manufacturing capabilities are complemented by an in-house quality testing laboratory.

Job Description
  • Receiving Of Incoming Materials and Finished Goods
  • Transferring of Materials and Finished Goods according to status locations
  • Issuing of Materials and Finished Goods
  • Updating stock cards and log Books
  • Generating monthly reports of stock and expiry (for finance, quality and customer)
  • Writing SOPs and fine-tuning of warehouse procedures
This position is already closed and no longer available.  You may like to view the other latest internships here.

Discuss this Job:

You can discuss this job on Clublance.com #career-jobs channel, or chat with other community members for free:
Share This Page